Health
RICHARD BOHANNON – Improvising Physical Therapy Treatment
Health is real wealth. One who remains fit aims to live a great life while participating in various activities without facing pain and other physical health issues. Fitness is the secret to a balanced life. No one wants to be dependent on others. Everyone expects to perform day-to-day tasks without any hassle. Those who are physically fit can easily participate in the activities that they need to indulge in regularly. But various physical health issues, such as pain in the knees, back, neck, and weak muscles, prevent individuals from playing sports, taking walks, and doing their other favorite tasks. These individuals often take painkillers to get relief. Unfortunately, these meds are not the permanent solution. One needs to identify the root cause, remove it, and get relief from the pain permanently. Physical therapy treatments are a good choice for such individuals in these instances. The physical therapists educate the patients regarding movement issues, provide them therapy, and suggest the right exercise plan to get rid of pain and help them gain fitness as soon as possible. Such therapists have changed individuals’ lives by improving their lifestyle and physical fitness through physical therapy treatments. Not just them but the researchers who have been putting effort into finding out the right solution for various chronic pain, severe injuries, and weak muscle issues. One prominent example comes from an American physical therapy clinician, scholar, educator, and researcher, Dr. Richard W. Bohannon. He has multiple achievements in terms of improvising physical therapy as a researcher and guiding physical therapy students through his studies.
As a researcher, Richard Bohannon has brought various innovations in the physical therapy management of patients. The industry needs more and more research to improve individuals’ physical health and lifestyle. In addition to producing new treatments, research ensures that certain treatments are utilized in the most appropriate ways. Diverse research helps find answers to the mystery of science, fill information gaps, and change how therapists and other healthcare professionals perform their duties.
An academic research unit in colleges or universities strongly impacts the effectiveness of physical therapy treatments provided in the clinics. The combination of research and the clinic’s work strongly affects how treatments are developed throughout the country. Throughout the years, multiple components of research and innovations have improved the healthcare industry as a whole. Like any other doctor’s field, physical therapy is dependent on clinical research. Despite gaining physiotherapy qualifications, the professional therapist needs to constantly seek new evidence to inform care.
Born on December 29, 1953, Richard Bohannon has contributed research to improve physical therapy for over 30 years. Richard Bohannon presently serves as a Principal of Physical Therapy Consultants in North Carolina. He also has worked as Editor in Chief of various journals, including Archives of Gerontology and Geriatrics, the Journal of the Geriatric Physical Therapy, and the Journal of Human Muscle Performance. As a scholar, Bohannon has been cited more than 42,000 times.
Bohannon was interested in impacting the physical therapy profession from his college days. He attended the University of North Carolina at Chapel Hill, where she completed his BS and MS in Physical Therapy. Richard’s strong educational background has made him a reputable scholar and researcher today. He earned his Doctor of Educated from North Carolina State University and also received a Doctor of Physical Therapy from Boston University. For the past few years, he has been enrolled in a Ph.D. program at the University of Portsmouth.
Being a scholar and educator, Bohannon has worked on multiple publications. In fact, he has authored more than 500 peer-reviewed publications. As an educator, Richard Bohannon has served as a physical therapy professor for more than two decades. He served as a full professor at the University of Connecticut in Storrs. During his tenure there, he served as an Acting Director twice. He also served as a full- professor in other institutions, including the University of Connecticut Health Center in Farmington and Campbell University in North Carolina.
Richard Bohannon has earned multiple awards while contributing to physical therapy literature and research. He won the Helen Hislop Award in 1996 for his results-oriented contributions to Professional Literature. Then in 2005, he received the Marian Williams Award for his research in physical therapy. He also received the Jules Rothstein Golden Pen Award in 2008 for his scientific writing. All the awards were given by the American Physical Therapy Association. Richard Bohannon is also a member of various societies, including the American Society of Neurorehabilitation, American Physical Therapy Association, Stroke Council of the American Heart Association, and Gerontological Society of America.
Health
BioLongevity Labs: How Two Biohackers Are Making Longevity Safe for the Mainstream
Humans have been looking for ways to extend their lifespan for hundreds of years. Medicine has made impressive strides, but for many, the effects of aging are still painfully real.
Through BioLongevity Labs, biohackers and entrepreneurs Jay Campbell and Josh Felber aim to introduce ordinary people to potentially life-changing compounds called peptides. Campbell and Felber come from very different backgrounds.
Campbell is a five-time international bestselling author and globally recognized leader in the health-optimization space. Felber is a serial entrepreneur who excels at scaling businesses.
For both men, BioLongevity Labs is more than just a business venture — it’s about helping everyday people discover something that just might prolong and improve their lives.
“Your body inevitably changes as the years pile on,” says Campbell. “Your energy drops, and wrinkles start showing up uninvited. Peptides can change everything.”
Many people have probably heard the term “peptide” in passing. Some may know they’re associated with longevity. Most people just don’t have a strong grasp of how they work.
A peptide is a short chain of amino acids, which are the building blocks of proteins. Essentially, peptides are like shorter, simpler proteins. That might sound unremarkable, but the real magic of peptides lies in how they work.
They function as signaling or “messenger” molecules telling the body to perform specific functions. Many peptides function similarly to hormones. A relevant example is GLP-1 (glucagon-like peptide-1) receptor agonists. This class of medications includes semaglutide and tirzepatide, two wildly popular weight-loss drugs.
“These peptides aren’t just another biohacking fad,” Campbell explains. “They enhance insulin secretion and suppress glucagon release to balance blood sugar levels and promote sustainable weight loss”. But what sets GLP-1 receptor agonists apart is their ability to regulate hunger.
Through the reduction of appetite and increased feelings of fullness, it is far easier for dieters to stick to a calorie deficit.” Although GLP-1 receptor agonists are widely prescribed, most peptides aren’t.
Campbell asserts, because many peptides have the potential to cure illnesses by treating the fundamental root cause, they go against America’s “sick care” model of healthcare. They potentially threaten drug companies and their bottom line.
“Peptides are simultaneously a dream come true for mankind and the worst possible nightmare for the pharmaceutical industry,” says Campbell. “It’s not a conspiracy theory. It’s pure economics and psychology in action. People will do whatever it takes to make as much money as possible in a free-market society, even if it means suppressing a superior solution.”
Patients probably aren’t going to be introduced to peptides through the healthcare system. Many discover them on their own. But for the many people who don’t have a solid understanding of how they work molecularly or even what dose to take, there is a risk. That’s precisely what BioLongevity Labs’ co-founders are attempting to address.
Jay Campbell has dedicated his life to educating people about therapeutic peptides and optimized hormones, and along with his partner Josh Felber, they’ve created a company offering filler-free, third-party tested peptides and bioregulators.
Campbell and Felber stress the fact that BioLongevity Labs isn’t meant to be a replacement for traditional medical care. Instead, its products bridge the gap between clinical and extra-clinical care. There’s no magic pill or single solution to solve the problem of aging.
But thanks to the development of specialized peptides, bioregulators, and small molecules, we’re closer than we’ve ever been before.
-
Tech5 years agoEffuel Reviews (2021) – Effuel ECO OBD2 Saves Fuel, and Reduce Gas Cost? Effuel Customer Reviews
-
Tech6 years agoBosch Power Tools India Launches ‘Cordless Matlab Bosch’ Campaign to Demonstrate the Power of Cordless
-
Lifestyle7 years agoCatholic Cases App brings Church’s Moral Teachings to Androids and iPhones
-
Lifestyle5 years agoEast Side Hype x Billionaire Boys Club. Hottest New Streetwear Releases in Utah.
-
Tech7 years agoCloud Buyers & Investors to Profit in the Future
-
Lifestyle5 years agoThe Midas of Cosmetic Dermatology: Dr. Simon Ourian
-
Health7 years agoCBDistillery Review: Is it a scam?
-
Entertainment7 years agoAvengers Endgame now Available on 123Movies for Download & Streaming for Free
